| 【Company Research】PICC P&C (2328 HK) – Strong beat in 1H22 |
| 【Company Research】CPIC (2601 HK) – VNB growth turned positive in June |
| 【Company Research】UEG (467 HK) – On track volume growth along with good cost control |
| 【Company Research】Meituan (3690 HK) – More bullish on 2H22E recovery and profitability |
| 【Company Research】Tigermed (300347 CH) – Solid growth amid COVID-19 outbreaks |
| 【Company Research】Recbio Technology (2179 HK) – Smooth progress of core pipeline products |
| 【Company Research】Wingtech (600745 CH) – 2Q results in line; Maintain BUY |
| 【Company Research】Innolight (300308 CH) – Overseas data center demand to remain resilient in 2H22 |
| 【Company Research】Huitongda Network (9878 HK) – Resilient growth in 2H22 |
| 【Company Research】Innovent Biologics (1801 HK) – Fast expanding commercial product portfolio |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
